skip to Main Content
NEWS

Press Release

NEWS

Biogennix Ramps Up National Distribution for Bone Graft Substitute Products osteoSPAN and Morpheus

Release Summary

These products have been so well received by the clinician and patient communities that it makes sense that we expand our distribution on a nationwide level.

More News
Biogennix Reports Additional 33% Growth in Q1
read more
Biogennix Bone Graft Substitute Materials Used to Treat 6000th Patient
read more
Biogennix Reports Record Growth for 2017; Expands Executive Management Team
read more
Contacts

Medialine Communications, 310-569-0023
paul@medialinecommunications.com

October 24, 2017 02:37 PM Eastern Daylight Time

IRVINE, Calif.–(BUSINESS WIRE)–Irvine-based Biogennix, an osteobiologics company which develops, manufactures, and distributes proprietary bone graft substitutes used for bone fusion procedures, announced today that it is expanding its distribution efforts for its novel bone graft substitutes, Morpheus and osteoSPAN to full national distribution.

The products are resorbable, moldable, osteoconductive scaffolds ideally suited for bone regeneration and optimal handling by surgeons.

News of Biogennix’s decision to expand its marketing of the products to a national level follows on the heels of last month’s announcement that Morpheus and osteoSPAN have now been used in more than 6000 patients.

“Our regionally focused efforts to market Morpheus and osteoSPAN bone graft products have exceeded expectations thus far,” said Scott Bauccio, Biogennix’s Vice President of Sales and Business Development. “We believe these products are fast becoming the new standard of effectiveness and ease of use when it comes to bone graft substitutes. They have been so well received by the clinician and patient communities that it makes sense that we expand our distribution on a nationwide level.”

Bauccio added that he and other key members of Biogennix’s executive team are attending the North American Spine Society (NASS) Meeting in Orlando this week, meeting with potential spine sales team members and reps as part of the growth phase.

Biogennix is a leading developer of osteobiologic products specifically designed for spine fusion and bone trauma. The company is led by a team of scientists and industry veterans committed to delivering unique products for bone regeneration. Biogennix designs, manufactures and distributes all of its products from its Irvine facilities.

Biogennix is a fully-integrated osteobiologic company headquartered in Irvine which develops, manufactures, and distributes proprietary bone graft substitutes used in bone fusion procedures. Learn more at biogennix.com.

Contacts for Biogennix
Medialine, 310-569-0023
paul@medialinecommunications.com

Back To Top
×Close search
Search